Skip to content
S7097Senate2021-2022 SessionSame asA8004

Cover Remotely Connected Insulin Pens

Official title

“Provides coverage for remotely connected insulin pens for certain patients with diabetes”

Sponsor Jeremy CooneySD-56Affects Health
Status
In Senate Committee
Health
Impact
6/10
Moderate
Passage
0%

Bill progress

Step 2 of 7

In committee · Health

What's happening

This bill requires Medicaid to cover remotely connected insulin pens for diabetic patients, including children with adult supervision.

Why it matters

  1. Expands access to advanced diabetes technology. by mandating Medicaid coverage for remotely connected insulin pens, which can improve disease management and outcomes for patients who might otherwise struggle with traditional insulin delivery.

  2. Addresses pediatric needs. by allowing children under seven to use these devices with adult supervision, helping families manage childhood diabetes more safely and conveniently at home.

  3. Requires managed care organizations to account for costs. associated with both the devices and their administration in premium payments, which could influence how Medicaid plans budget and negotiate for diabetes care.

  4. May encourage broader adoption and innovation. in digital health tools for diabetes management by making them more accessible to low-income populations, potentially reducing long-term healthcare costs through better disease control.

The daily · weekday mornings

Albany, before your first meeting.

Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.

Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.

Headline styles

Cover Remotely Connected Insulin Pens

Plain English, a few words. Used as the page title.

Sponsors

Primary sponsor
Jeremy Cooney

Senator · Senate District 56

Chair, Cities 2

No co-sponsors yet.

History

  1. Referred to health
  2. Referred to health

Companion bill

The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.

A8004Assembly

Cover Smart Insulin Pens

In Assembly Committee · Health · Sponsor Kimberly Jean-Pierre

Impact 6 · Moderate0% to pass

Full text

1 pageUnderlined is new[Struck] is removedOfficial text on nysenate.gov ↗

STATE OF NEW YORK

7097

2021-2022 Regular Sessions

IN SENATE

May 28, 2021

Introduced by Sen. COONEY -- read twice and ordered printed, and when printed to be committed to the Committee on Health

AN ACT to amend the social services law, in relation to coverage for assistance for remotely connected insulin pens for certain patients with diabetes

The People of the State of New York, represented in Senate and Assembly, do enact as follows:

Section 1. Subdivision 2 of section 365-a of the social services law is amended by adding a new paragraph (ii) to read as follows:

(ii) Remotely connected insulin pens for patients with diabetes that can operate interactively and/or autonomously for recipients who are seven years of age or older and will be using such a device solely with appropriately prescribed insulin cartridges; provided recipients younger than seven years old may use the remotely connected insulin delivery device with adult supervision. Coverage of such remotely connected insulin pens shall be provided under the pharmacy benefit of medical assistance for all eligible patients with diabetes and the cost of such services, including the cost to administer such benefit, shall be adequately reflected in managed care organization premium payments.

§ 2. This act shall take effect January 1, 2022.

EXPLANATION--Matter in italics (underscored) is new; matter in brackets

[ ] is old law to be omitted.

LBD11732-01-1

Reflowed for reading: line numbers and page breaks removed. Cite the official text.

Sponsor's memo

Title of bill

An act to amend the social services law, in relation to coverage for assistance for remotely connected insulin pens for certain patients with diabetes

Summary of specific provisions

Section one requires that remotely connected insulin pens for patients with diabetes that can operate interactively and/or autonomously shall be covered under the pharmacy benefit of medical assistance for all eligible patients with diabetes and the cost of such services shall be reflected in managed care organization premium payments.

Section two provides the effective date.

Justification

Insulin pens are a life-saving device for many with diabetes, and the technology for these pens is ever-evolving. Certain new insulin pens have wireless capability, allowing users to operate and administer via mobile app. Such apps can keep track of insulin and glucose levels, send reminders to dose, and even create multi-monthly reports for users to more effectively manage their health.

New technology, like these insulin pens, has to be approved for inclu- sion in Medicaid by the Medicaid Evidence-Based Benefit Review Advisory Committee within the Department of Health. However, as this committee has not met since 2017, Medicaid recipients across the state are deprived of these new devices that can help better manage their condi- tions. In the absence of action by the committee, adding these new insu- lin pens to Medicaid coverage in the law is the only way those with diabetes will have access to this technology that may save their lives.

Prior legislative history

This is a new bill.

Fiscal implication

To be determined.

Effective date

This act shall take effect January 1, 2022.

Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.